BioSniper
ZH
Toggle language
Open menu
Phase 2 Readout
~quarter
Phase 2 Readout: gt-02287
September 30, 2026
Company
Gain Therapeutics, Inc. (GANX)
Drug
gt-02287
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Start Free
Full Calendar
GANX Overview
PDUFA Dates
Phase 3 Readouts
Phase 2 Readout: gt-02287 — GANX Phase 2 Readout | BioSniper